Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Verekitug by Upstream Bio for Rhinosinusitis: Likelihood of Approval
Verekitug is under clinical development by Upstream Bio and currently in Phase II for Rhinosinusitis. According to GlobalData, Phase II...
Data Insights
Verekitug by Upstream Bio for Asthma: Likelihood of Approval
Verekitug is under clinical development by Upstream Bio and currently in Phase II for Asthma. According to GlobalData, Phase II...